---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-137418"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T16:51:50.765649+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Lyra posts corporate presentation; no financial results disclosed

## Summary
- Filing indicates presentation posted to website for investor discussions.
- No specific financial or operational updates contained in the 8-K.
- Presentation likely contains pipeline and strategy overview; details not provided.

## SEC filing metadata
- accession: 0001193125-25-137418
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000119312525137418/0001193125-25-137418-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000119312525137418/d72549d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-137418
- JSON: https://secwatch.observer/filing/0001193125-25-137418.json
- Plain text: https://secwatch.observer/filing/0001193125-25-137418.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.